Colleen Johnson, MD
Otolaryngology · Kansas City, KSNPI 1033301510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Sanofi at 25.5% of the total. 2025 is the largest year on record at $454, 2.6 times the $176 reported in 2019.
Across 90 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$459
- Optinose US, Inc.$339
- Regeneron Healthcare Solutions, Inc.$242
- Aerin Medical Inc.$157
- Stryker$110
- Acclarent, Inc$83
- plus $410 from 11 others
What the payments were for
- Food & beverage$1,74497%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 27 | $459 |
| Optinose US, Inc. | 24 | $339 |
| Regeneron Healthcare Solutions, Inc. | 9 | $242 |
| Aerin Medical Inc. | 4 | $157 |
| Stryker | 5 | $110 |
| Acclarent, Inc | 3 | $83 |
| GSK | 4 | $71 |
| Intersect ENT, Inc. | 3 | $64 |
| Smith+Nephew | 2 | $63 |
| AbbVie | 2 | $44 |
| Medtronic | 1 | $43 |
| Olympus America Inc. | 1 | $29 |
| Globus Medical | 1 | $27 |
| Ambu Inc. | 1 | $22 |
| Kaleo, Inc. | 1 | $19 |
| Vertex | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
How this compares
$1,800 in reported general payments places this provider in the 60th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefpodoxime Proxetil | 15 | $2,164 |
| Epinephrine | 13 | $1,768 |
| Azelastine Hcl | 56 | $1,758 |
| Ipratropium Bromide | 50 | $1,457 |
| Omeprazole | 42 | $1,074 |
| Famotidine | 56 | $993 |
| Fluticasone Propionate | 63 | $872 |
| Ofloxacin | 22 | $424 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $379 |
| Mupirocin | 37 | $362 |
| Levothyroxine Sodium | 14 | $264 |
| Prednisone | 57 | $163 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $110 |
| Methylprednisolone | 11 | $55 |
| Montelukast Sodium | 15 | $12 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Kansas City
- Hinrich StaeckerKansas City$499K
- Jennifer VillwockKansas City$26K
- Meha FoxKansas City$12K
- Kiran KakaralaKansas City$10K
- Andres BurKansas City$10K
- Christopher LarsenKansas City$8K
- John KrietKansas City$6K
- Justin BondKansas City$4K
- Mohammad Ameen AmanianKansas City$3K
- Frantzlee LacreteKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.